转移性食管的临床试验
总计13908个结果
-
Parker Institute for Cancer ImmunotherapyBristol-Myers Squibb; Cancer Research Institute, New York City完全的
-
Ohio State University Comprehensive Cancer Center招聘中
-
Daiichi SankyoAstraZeneca招聘中
-
Memorial Sloan Kettering Cancer CenterRepare Therapeutics招聘中
-
Imperial College LondonCuresponse Ltd.尚未招聘
-
Meryx, Inc.主动,不招人
-
Samsung Medical Center完全的
-
P.O. WitteveenErasmus Medical Center; The Netherlands Cancer Institute终止
-
Virginia Commonwealth University终止
-
UNICANCERNational Cancer Institute, France招聘中
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany完全的
-
Innovent Biologics (Suzhou) Co. Ltd.尚未招聘
-
Imperial College LondonUniversity College London Hospitals; Northern Care Alliance NHS Foundation Trust; Nottingham University... 和其他合作者招聘中
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityMassachusetts General Hospital; Guangdong Provincial People's Hospital完全的
-
Jacobio Pharmaceuticals Co., Ltd.招聘中
-
Jacobio Pharmaceuticals Co., Ltd.招聘中
-
Jonsson Comprehensive Cancer CenterMedivation, Inc.; BioMarin Pharmaceutical; Translational Research in Oncology完全的
-
University Hospital, LilleGroupement Interrégional de Recherche Clinique et d'Innovation; french patient association for...尚未招聘
-
Royal Marsden NHS Foundation Trust完全的
-
The Belgian Society of Medical OncologyRoche Pharma AG; Foundation Medicine; Sciensano招聘中
-
Oslo University HospitalThe Research Council of Norway完全的
-
Millennium Pharmaceuticals, Inc.终止转移性胃腺癌 | 转移性胃食管结合部腺癌 | 胃食管结合部腺癌 | 复发性胃腺癌 | 复发性胃食管结合部腺癌 | 晚期胃肠癌 | 复发性胃肠癌台湾, 大韩民国, 日本
-
University Hospital, Basel, Switzerland尚未招聘
-
Cristal Therapeutics完全的
-
AstraZeneca完全的具有腺癌和非腺癌组织学的 aNSCLC 患者(局部晚期和/或转移性疾病)的 EGFR 突变状态。意大利, 西班牙, 英国, 瑞典, 日本, 荷兰, 德国, 法国
-
Assistance Publique Hopitaux De Marseille未知